therapy
METHODS AND       RESULTS: Eighty-three symptomatic stable patients with chronic heart failure       receiving long-term ACE inhibitor therapy were randomly assigned to double-blind        treatment with valsartan 80 mg BID, valsartan 160 mg BID, or placebo while       receiving their usual ACE inhibitor therapy.
METHODS AND       RESULTS: Eighty-three symptomatic stable  @OBJECT$  with chronic heart failure       receiving long-term ACE inhibitor therapy were randomly assigned to double-blind        treatment with valsartan 80 mg BID, valsartan 160 mg BID, or placebo while        @PREDICAT$  their usual ACE inhibitor  @SUBJECT$ .